Literature DB >> 31173385

Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.

Giacomo Coltro1, Terra L Lasho1, Christy M Finke1, Naseema Gangat1, Animesh Pardanani1, Ayalew Tefferi1, Dragan Jevremovic2, Jessica K Altman3, Mrinal M Patnaik1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31173385     DOI： 10.1002/ajh.25552

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

1.  The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation.

Authors:  Krishna Gundabolu; Bhavana J Dave; Carmelita J Alvares; Jeffrey J Cannatella; Vijaya R Bhatt; Lori J Maness; Zaid S Al-Kadhimi; Rana K Zabad; Allison M Cushman-Vokoun
Journal:  Case Rep Genet       Date:  2022-03-01

2.  Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.

Authors:  Francesco Baccelli; Davide Leardini; Edoardo Muratore; Daria Messelodi; Salvatore Nicola Bertuccio; Maria Chiriaco; Caterina Cancrini; Francesca Conti; Fausto Castagnetti; Lucia Pedace; Andrea Pession; Ayami Yoshimi; Charlotte Niemeyer; Marco Tartaglia; Franco Locatelli; Riccardo Masetti
Journal:  Hum Genomics       Date:  2022-09-19       Impact factor: 6.481

Review 3.  The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis.

Authors:  Rhiannon Morris; Liesl Butler; Andrew Perkins; Nadia J Kershaw; Jeffrey J Babon
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.